CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System
System to be launched at Society of Toxicology’s 2021 Virtual Annual Meeting, March 12-26th, 2021
Articles by CN Bio
CN Bio Awarded Innovate UK Grant to Develop Single and Multi-Organ Models for COVID-19 Research
The funding will be used to develop and test advanced cell culture models that represent different regions of the lung
CN Bio’s PhysioMimix Technology Receives FDA Recognition
FDA publication demonstrates advantages of PhysioMimix in drug safety and metabolism applications over standard techniques
CN Bio to Provide Drug Metabolism and Safety Toxicity Testing Services
Extended range of services supports accelerated drug discovery and development using predictive 3D Liver-on-Chip technology